NCT04361994

Brief Summary

GEIST is a multicenter, international observational registry of patients with Takotsubo syndrome. Data regarding the clinical profile (demographic characteristics, clinical presentation, laboratory measures, electrocardiography /echocardiography / coronary angiography parameters, treatment and medication), in-hospital course and complications and short-/long-term outcome are collected prospectively and retrospectively to increase the understanding of the disease.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
117mo left

Started Apr 2015

Longer than P75 for all trials

Geographic Reach
2 countries

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Apr 2015Dec 2035

Study Start

First participant enrolled

April 1, 2015

Completed
5.1 years until next milestone

First Submitted

Initial submission to the registry

April 22, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 24, 2020

Completed
15.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2035

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2035

Last Updated

December 26, 2025

Status Verified

December 1, 2025

Enrollment Period

20.7 years

First QC Date

April 22, 2020

Last Update Submit

December 18, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • All-cause mortality

    All-cause mortality (in-hospital, short-term, long-term)

    Day 0

  • All-cause mortality

    All-cause mortality (in-hospital, short-term, long-term)

    3 Month

  • All-cause mortality

    All-cause mortality (in-hospital, short-term, long-term)

    6 Month

Secondary Outcomes (1)

  • In-Hospital complications

    Day 0

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Diagnosed according to the current diagnostic recommendations at the time of clinical presentation

You may qualify if:

  • Patients with Takotsubo syndrome

You may not qualify if:

  • Non

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Universität zu Lübeck

Lübeck, Schleswig-Holstein, 23538, Germany

RECRUITING

University of Foggia

Foggia, Italy

RECRUITING

Related Publications (5)

  • Raposeiras-Roubin S, Santoro F, Arcari L, Vazirani R, Novo G, Uribarri A, Enrica M, Lopez-Pais J, Guerra F, Alfonso F, Patz T, Fernandez-Cordon C, Montisci R, Corbi-Pascual M, Marchetti MF, Almendro M, Cacciotti L, Vedia O, El-Battrawy I, Blanco-Ponce E, Brunetti ND, Akin I, Martinez-Selles M, Thiele H, Stiermaier T, Eitel I, Nunez-Gil IJ; GEIST Researchers. Beta-Blockers and Long-Term Mortality in Takotsubo Syndrome: Results of the Multicenter GEIST Registry. JACC Heart Fail. 2025 May;13(5):815-825. doi: 10.1016/j.jchf.2024.11.015. Epub 2025 Feb 5.

  • Santoro F, Stiermaier T, Nunez Gil IJ, El-Battrawy I, Patz T, Cacciotti L, Guerra F, Novo G, Musumeci B, Volpe M, Mariano E, Caldarola P, Montisci R, Ragnatela I, Cetera R, Vazirani R, Lluch C, Uribarri A, Corbi-Pascual M, Conty Cardona DA, Akin I, Barbato E, Thiele H, Brunetti ND, Eitel I, Arcari L. Renin angiotensin system inhibitors and outcome in patients with takotsubo syndrome: A propensity score analysis of the GEIST registry. Am Heart J. 2024 Dec;278:127-138. doi: 10.1016/j.ahj.2024.08.019. Epub 2024 Sep 10.

  • El-Battrawy I, Santoro F, Nunez-Gil IJ, Patz T, Arcari L, Abumayyaleh M, Guerra F, Novo G, Musumeci B, Cacciotti L, Mariano E, Caldarola P, Parisi G, Montisci R, Vitale E, Volpe M, Corbi-Pasqual M, Martinez-Selles M, Almendro-Delia M, Sionis A, Uribarri A, Thiele H, Brunetti ND, Eitel I, Akin I, Stiermaier T. Age-Related Differences in Takotsubo Syndrome: Results From the Multicenter GEIST Registry. J Am Heart Assoc. 2024 Feb 20;13(4):e030623. doi: 10.1161/JAHA.123.030623. Epub 2024 Feb 13.

  • Stiermaier T, Walliser A, El-Battrawy I, Patz T, Mezger M, Rawish E, Andres M, Almendro-Delia M, Martinez-Selles M, Uribarri A, Perez-Castellanos A, Guerra F, Novo G, Mariano E, Musumeci MB, Arcari L, Cacciotti L, Montisci R, Akin I, Thiele H, Brunetti ND, Nunez-Gil IJ, Santoro F, Eitel I. Happy Heart Syndrome: Frequency, Characteristics, and Outcome of Takotsubo Syndrome Triggered by Positive Life Events. JACC Heart Fail. 2022 Jul;10(7):459-466. doi: 10.1016/j.jchf.2022.02.015. Epub 2022 May 4.

  • El-Battrawy I, Santoro F, Stiermaier T, Moller C, Guastafierro F, Novo G, Novo S, Mariano E, Romeo F, Romeo F, Thiele H, Guerra F, Capucci A, Giannini I, Brunetti ND, Eitel I, Akin I. Incidence and Clinical Impact of Right Ventricular Involvement (Biventricular Ballooning) in Takotsubo Syndrome: Results From the GEIST Registry. Chest. 2021 Oct;160(4):1433-1441. doi: 10.1016/j.chest.2021.04.072. Epub 2021 May 27.

MeSH Terms

Conditions

Takotsubo Cardiomyopathy

Condition Hierarchy (Ancestors)

CardiomyopathiesHeart DiseasesCardiovascular DiseasesVentricular Dysfunction, LeftVentricular Dysfunction

Central Study Contacts

Ingo Eitel, Prof. Dr.

CONTACT

Thomas Stiermaier, Dr.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

April 22, 2020

First Posted

April 24, 2020

Study Start

April 1, 2015

Primary Completion (Estimated)

December 1, 2035

Study Completion (Estimated)

December 1, 2035

Last Updated

December 26, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations